The protective effect of Ginsenoside Rg1 on aging mouse pancreas damage induced by D-galactose

Zhaoying Dong1, Mengxiong Xu2, Jie Huang2

  • 1Chongqing Medical University, Affiliated First Clinical College, Yuzhong, Chongqing 400016, P.R. China.

Insights

Ginsenoside Rg1 protects the aging mouse pancreas from D-galactose-induced damage by reducing oxidative stress. This study reveals Rg1

Area of Science:

  • Gerontology
  • Pharmacology
  • Biochemistry

Background:

  • Aging is associated with pancreatic dysfunction.
  • D-galactose (D-gal) induces aging-like changes and pancreatic damage in mice.
  • Ginsenoside Rg1 is a potential therapeutic agent.

Purpose of the Study:

  • To investigate the protective effects of Ginsenoside Rg1 against D-gal-induced pancreatic aging.
  • To elucidate the underlying mechanisms of Rg1's protective action.

Main Methods:

  • D-galactose induction of pancreatic aging in C57BL/6J mice.
  • Treatment with Ginsenoside Rg1.
  • Assessment of pancreatic morphology, glucose metabolism, oxidative stress markers (SOD, MDA, T-AOC), advanced glycation end products (AGEs), and senescence-associated β-galactosidase (SA-β-gal).

Main Results:

  • Rg1 treatment significantly reduced pancreatic wet weight, visceral index, and fasting blood glucose.
  • Rg1 mitigated D-gal-induced declines in islet cell number and size.
  • Rg1 decreased oxidative stress, AGEs, and SA-β-gal expression, while increasing antioxidant capacity.

Conclusions:

  • Ginsenoside Rg1 exhibits protective effects against D-galactose-induced pancreatic injury in aging mice.
  • The mechanism involves the reduction of oxidative damage and cellular senescence.
  • Rg1 holds potential for mitigating age-related pancreatic dysfunction.

Related Concept Videos